family testimonial of simufilam trials w/ hilary metz | cassava sciences stock | sava | joe springer
Published Streamed 2 years ago • 5.2K plays • Length 44:53Download video MP4
Download video MP3
Similar videos
-
0:43
caregiver testimonials #1 / 9 -- cassava sciences alzheimer's simufilam trial
-
0:56
caregiver testimonials #3 / 9 -- cassava sciences alzheimer's simufilam trial
-
16:31
highlights of family testimonials in cassava sciences alzheimer's phase 2 simufilam trials
-
1:00
caregiver testimonials #7 / 9 -- cassava sciences alzheimer's simufilam trial
-
5:05
simufilam patient testimonials #1 | cassava sciences sava | joe springer
-
29:21
hilary metz -- family testimonial for cassava sciences open-label simufilam alzheimer's trial
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
42:43
the tiny biotech transforming alzheimer's treatment
-
36:34
cassava sciences ceo remi barbier interview | joe springer
-
6:56
hilary metz - family testimonial for cassava sciences open-label simufilam alzheimer's trial (short)
-
12:28
cassava sciences stock | top 10 stories in alzheimer's | sava | joe springer
-
33:23
interview with families of patients in cassava sciences' p2 alzheimer's trial (just interviewees)
-
49:41
strem2 best indicator of alzheimer's | biotech stocks | cassava sciences sava | joe springer
-
2:54
clinical trial: simufilam for alzheimer's disease (nct05026177)
-
44:08
neurologist interview on alzheimer's disease, cassava sciences' data | sava
-
![3 huge catalysts for cassava sciences in the next month | [$sava] stock](https://i.ytimg.com/vi/w2XFiS--k34/mqdefault.jpg)
28:21
3 huge catalysts for cassava sciences in the next month | [$sava] stock
-
33:33
cassava sciences new presentation and fireside chat | stocks avxl sava xbi xle xly | joe springer
-
![cassava sciences stock - an intro | stocks [$sava]](https://i.ytimg.com/vi/QqmuwN8dgQQ/mqdefault.jpg)
1:00:33
cassava sciences stock - an intro | stocks [$sava]
-
1:08:47
neurologist dr. lewis robinson on simufilam | cassava siences | sava biotech stock | joe springer
-
40:19
87,000 options expiring explains new yorker hit piece | cassava sciences stock | sava | joe springer
-
36:30
cassava sciences stock | fed whipsaw | sava | joe springer
-
31:49
dr. edward boyer on alzheimer's disease, cassava sciences, data, epilepsy, simufilam | sava stock